Genesys International Corporation Ltd

Genesys International Corporation Limited announced the appointment of M/s. G. K. Choksi & Co. as its Statutory Auditors for a five-year term, replacing M/s. MSKA & Associates, and M/s. XAG & Co. as its Internal Auditor, effective September 2, 2026. The company also approved the introduction of the “Genesys ESOP Scheme – 2026,” which proposes to grant up to 30,00,000 stock options, and approved adjustments to outstanding stock options under the Genesys ESOP Scheme – 2022 following a rights issue, resulting in the grant of 1,82,640 additional options. Additionally, the Board noted the resignation of M/s. H.C. Vora & Associates as Internal Auditor and approved the convening of the 44th Annual General Meeting on September 30, 2026.

Genesys International Corporation Limited will hold a meeting of its Board of Directors on Wednesday, September 02, 2026, to consider and approve the Genesys Employee Stock Option Scheme – 2026, subject to shareholder approval, as well as other matters.

Fertilizers & Chemicals Travancore Ltd, Khandwala Securities Ltd, Medi Caps Ltd and JHS Svendgaard Retail Ventures Ltd are among the other gainers in the BSE's 'B' group today, 25 August 2026.Genesys International Corporation Ltd soared 19.99% to Rs 214.3 at 12:03 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 2.45 lakh shares were traded on the counter so far as against the average daily volumes of 30449 shares in the past one month. Fertilizers & Chemicals Travancore Ltd spiked 14.45% to Rs 897.75. The stock was the second biggest gainer in 'B' group. On the BSE, 15.31 lakh shares were traded on the counter so far as against the average daily volumes of 8854 shares in the past one month. Khandwala Securities Ltd surged 12.89% to Rs 19.09. The stock was the third biggest gainer in 'B' group. On the BSE, 940 shares were traded on the counter so far as against the average daily volumes of 1063 shares in the past one month. Medi Caps Ltd gained 12.74% to Rs 27.69. The stock was the fourth biggest gainer in 'B' group. On the BSE, 41 shares were traded on the counter so far as against the average daily volumes of 2204 shares in the past one month. JHS Svendgaard Retail Ventures Ltd jumped 12.10% to Rs 18.99. The stock was the fifth biggest gainer in 'B' group. On the BSE, 1 shares were traded on the counter so far as against the average daily volumes of 775 shares in the past one month.

Genesys International Corporation Limited announced on August 24, 2026, that its Board of Directors approved the allotment of 2,50,74,226 equity shares with a face value of Rs 5 each at an issue price of Rs 50 per share, including a premium of Rs 45 per share, on a rights basis. The allotment, finalized in consultation with Bigshare Services Private Limited and approved by the BSE Limited, increases the company’s paid-up equity share capital from Rs 20.89 crore to Rs 33.34 crore.

Genesys International Corporation Limited will hold a board meeting on Friday, August 14, 2026, at its registered office to approve the unaudited financial results (standalone and consolidated) for the first quarter ended June 30, 2026, as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Genesys International Corporation Limited announced a rights issue of 2,50,74,226 equity shares, with a face value of Rs 5 each, at a price of Rs 50 per share, including a premium of Rs 45, to its eligible shareholders as on August 6, 2026. The rights issue ratio is 3 shares for every 5 shares held, and the total amount to be raised will not exceed Rs 12,537.11 lakhs, with the Rights Issue opening on August 14, 2026, and closing on August 21, 2026, subject to a possible extension.

Genesys International Corporation will hold a meeting of the Board of Directors of the Company on 31 July 2026.

The board of Genesys International Corporation at its meeting held on 26 June 2026 has approved fund raising by way of rights issue for an amount not exceeding Rs 139.30 crore.

Genesys International Corporation will hold a meeting of the Board of Directors of the Company on 26 June 2026.

Net profit of Genesys International Corporation declined 34.78% to Rs 12.36 crore in the quarter ended March 2026 as against Rs 18.95 crore during the previous quarter ended March 2025. Sales rose 10.68% to Rs 104.22 crore in the quarter ended March 2026 as against Rs 94.16 crore during the previous quarter ended March 2025. For the full year,net profit declined 42.05% to Rs 32.58 crore in the year ended March 2026 as against Rs 56.22 crore during the previous year ended March 2025. Sales rose 5.39% to Rs 327.81 crore in the year ended March 2026 as against Rs 311.03 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales104.2294.16 11 327.81311.03 5 OPM %32.7252.86 -33.3645.69 - PBDT34.2046.80 -27 116.57137.70 -15 PBT17.0931.52 -46 51.5982.68 -38 NP12.3618.95 -35 32.5856.22 -42 Powered by Capital Market - Live